| Neutralising antibody activity against SARS-CoV-2 VOCs B. 1.617. 2 and B. 1.351 by BNT162b2 vaccination EC Wall, M Wu, R Harvey, G Kelly, S Warchal, C Sawyer, R Daniels, ... The Lancet 397 (10292), 2331-2333, 2021 | 600 | 2021 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 248 | 2020 |
| AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC EC Wall, M Wu, R Harvey, G Kelly, S Warchal, C Sawyer, R Daniels, ... The Lancet 398 (10296), 207-209, 2021 | 133 | 2021 |
| Three-dose vaccination elicits neutralising antibodies against omicron M Wu, EC Wall, EJ Carr, R Harvey, H Townsley, HV Mears, L Adams, ... The Lancet 399 (10326), 715-717, 2022 | 100 | 2022 |
| Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients EJ Carr, M Wu, R Harvey, EC Wall, G Kelly, S Hussain, M Howell, ... The Lancet 398 (10305), 1038-1041, 2021 | 92 | 2021 |
| A systematic benchmark of Nanopore long read RNA sequencing for transcript level analysis in human cell lines Y Chen, NM Davidson, YK Wan, H Patel, F Yao, HM Low, C Hendra, ... BioRxiv, 2021.04. 21.440736, 2021 | 63 | 2021 |
| Miniaturisation of high-throughput plasmid DNA library preparation for next-generation sequencing using multifactorial optimisation L Suckling, C McFarlane, C Sawyer, SP Chambers, RI Kitney, ... Synthetic and systems biotechnology 4 (1), 57-66, 2019 | 19 | 2019 |
| Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy S Balestrini, MJ Koepp, S Gandhi, HM Rickman, GY Shin, CF Houlihan, ... Epilepsy & Behavior 115, 107602, 2021 | 16 | 2021 |
| Neutralising immunity to omicron sublineages BQ. 1.1, XBB, and XBB. 1.5 in healthy adults is boosted by bivalent BA. 1-containing mRNA vaccination and previous Omicron infection EJ Carr, MY Wu, J Gahir, R Harvey, H Townsley, C Bailey, AS Fowler, ... The Lancet Infectious Diseases, 2023 | 9 | 2023 |
| Ability of AZD1222 vaccination to elicit neutralising antibodies against SARS-CoV-2 VOC B. 1.617. 2 (Delta) EC Wall, M Wu, R Harvey, G Kelly, S Warchal, C Sawyer, R Daniels, ... Lancet (London, England) 398 (10296), 207, 2021 | 2 | 2021 |
